Johnson & Johnson names ex-Sanofi executive as pharma, R&D vice president

This post was originally published on this site

Reed, 64, will replace William Hait, who was appointed the interim head of the unit in August 2022.

Reed has previously served in executive positions for drugmakers Sanofi (NASDAQ:SNY) SA and Roche Holding AG (OTC:RHHVF).